Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965

Rosie McNeillis; Alastair Greystoke; Jon Walton; Chris Bacon; Hector Keun; Alexandros Siskos; George Petrides; Nicola Leech; Fiona Jenkinson; Ann Bowron; Sarah Halford; Ruth Plummer

doi:10.1038/s41416-020-0801-2

Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965

Br J Cancer. 2020 Apr;122(8):1272. doi: 10.1038/s41416-020-0801-2.

Authors

Rosie McNeillis^#¹, Alastair Greystoke^#^{1

2}, Jon Walton¹, Chris Bacon^{1

2}, Hector Keun³, Alexandros Siskos³, George Petrides¹, Nicola Leech¹, Fiona Jenkinson¹, Ann Bowron¹, Sarah Halford⁴, Ruth Plummer^{5

6}

Affiliations

¹ Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
² Newcastle University, Newcastle upon Tyne, UK.
³ Imperial College London, London, UK.
⁴ Centre for Drug Development, Cancer Research UK, London, UK.
⁵ Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. ruth.plummer@newcastle.ac.uk.
⁶ Newcastle University, Newcastle upon Tyne, UK. ruth.plummer@newcastle.ac.uk.

^# Contributed equally.

Abstract

Since the publication of this paper the authors noticed an error in the listed authors, where Alexandros Siskos was listed as Alexandros Sitkos. This has now been corrected.

Publication types

Published Erratum

Abstract

Publication types

Grants and funding